Emerging evidences discussed above reinforce the importance of the pentraxins (CRP and PTX3 in particular) in complement activation and regulation in the pathogenesis of age-associated diseases and complement-dependent tumor-promoting inflammation. The gene discussed is PTX3; the disease is neoplasm.